Harm-to-Benefit of Three Decades of Prostate Cancer Screening in Black Men
Disclaimer: Publications may either be freely available or require a fee to view (or access) on the journal’s website.
Full Citation
Basourakos SP, Gulati R, Vince RA Jr, Spratt DE, Lewicki PJ, Hill A, Nyame YA, Cullen J, Markt SC, Barbieri CE, Hu JC, Trapl E, Shoag JE. Harm-to-Benefit of Three Decades of Prostate Cancer Screening in Black Men. NEJM Evid. 2022 Jun;1(6):10.1056/evidoa2200031. doi: 10.1056/evidoa2200031. Epub 2022 May 15. PMID: 35721307; PMCID: PMC9202998.
Tags
Journal Article Type
- Paper Resulting From PCORI-Funded Research Study (with results)
- Other Results
Journal Publication Name
- NEJM evidence
Literature Type
- PCORI Research